TMC Life Sciences Berhad's latest marketcap:
As of 06/27/2025, TMC Life Sciences Berhad's market capitalization has reached $176.62 M. According to our data, TMC Life Sciences Berhad is the 20839th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 176.62 M |
| Revenue (ttm) | 76.96 M |
| Net Income (ttm) | 520,410.6 |
| Shares Out | 1.74 B |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/05/2024 |
| Earnings Date | 08/22/2025 |
TMC Life Sciences Berhad's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/27/2025 | RM176.62 M | -14% | 20839 |
| 12/31/2024 | RM870.94 M | -30.07% | 19169 |
| 12/29/2023 | RM1.25 B | 13.49% | 17050 |
| 12/30/2022 | RM1.1 B | 18.87% | 16744 |
| 12/31/2021 | RM923.2 M | -19.7% | 18260 |
| 12/31/2020 | RM1.15 B | 4.76% | 14843 |
| 12/31/2019 | RM1.1 B | -13.43% | 13345 |
| 12/31/2018 | RM1.27 B | -14.61% | 11688 |
| 12/29/2017 | RM1.48 B | -10.34% | 11964 |
| 12/30/2016 | RM1.66 B | 34.57% | 10492 |
Company Profile
About TMC Life Sciences Berhad
TMC Life Sciences Berhad is an investment holding company specializing in healthcare services across Malaysia. Established in 1994 and headquartered in Petaling Jaya, the company operates under its parent company, Sasteria (M) Pte. Ltd.
Core Healthcare Services
The company's flagship facility, Thomson Hospital Kota Damansara (THKD), is a leading medical center in Selangor offering specialized services, including:
- Women and children's health
- Cancer treatment
- Orthopedics, ENT, and head & neck laser procedures
- Gastroenterology, hepatology, and urology
- Fertility and reproductive health services
Reproductive & Fertility Solutions
TMC Life Sciences provides advanced fertility treatments, such as:
- In-vitro fertilisation (IVF)
- Preimplantation genetic testing
- Fertility preservation
- Laparoscopic surgery and surgical sperm retrieval
- Donation programs and consultancy services
Additional Offerings
- Laboratory and embryology services
- Traditional and complementary medicine
- Pharmacy services and retail operations
- Management support for multi-disciplinary tertiary care
- Women's clinics and fertility centers
Other Activities
Beyond healthcare, the company engages in:
- Research and development initiatives
- Healthcare program development and management
- Property investment ventures
Frequently Asked Questions
-
What is TMC Life Sciences Berhad's (KLSE-TMCLIFE) current market cap?As of 06/27/2025, TMC Life Sciences Berhad (including the parent company, if applicable) has an estimated market capitalization of $176.62 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does TMC Life Sciences Berhad (KLSE-TMCLIFE) rank globally by market cap?TMC Life Sciences Berhad global market capitalization ranking is approximately 20839 as of 06/27/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.